Recombinant Fertilization Antigen-1 Causes a Contraceptive Effect in Actively Immunized Mice¹

^a Division of Research, Department of Obstetrics and Gynecology, Medical College of Ohio, Toledo, Ohio 43614

Recombinant (r) fertilization antigen (FA)-1 was investigated for its immunocontraceptive effect using the mouse as a model. Active immunization with the murine rFA-1 antigen raised high antibody titers in all the immunized mice (n = 16 in two trials); these titers were long lasting and reached preimmunization levels by the 255th day. There was a significant (p < 0.0001) effect (64% reduction in trial I and 70% reduction in trial II) in fertility of immunized animals compared to PBS-control animals (n = 22 in two trials). The effect on fertility was reversible. When the antibody titers declined to control levels, all the animals conceived and delivered healthy babies without a significant (p > 0.05) effect on the litter size compared to that of controls. There was a significant (p = 0.025) correlation (r = 0.76) between the reduction in fertility and the circulating rFA-1 antibody titers. Anti-rFA-1 antibodies from immunized mice, and not the immunoglobulins from the PBS-control mice, significantly (p < 0.001) blocked murine sperm binding to zona pellucida and in vitro fertilization of murine oocytes. In a Western blot procedure, the anti-rFA-1 antibodies specifically recognized the protein band of ~47 kDa (dimeric form of cognate FA-1 antigen) only in the protein extract of testes and not in the extracts of somatic tissues tested, namely kidney, liver, intestine, spleen, muscle, heart, lung, brain, and ovary. In conclusion, our data indicate that active immunization with rFA-1 antigen induces a strong and sperm/testis-specific antibody response that causes a reversible inhibition of fertility by affecting sperm-zona binding and the fertilization process. These findings suggest that rFA-1 antigen is an exciting candidate for the development of a contraceptive vaccine.

¹ Supported by NIH grant HD24425 to R.K.N.

² Correspondence: Rajesh K. Naz, Division of Research, Department of Obstetrics and Gynecology, Richard D. Ruppert Health Center, 3120 Glendale Avenue, Toledo, OH 43614. FAX: 419 383 4473; rnaz{at}gemini.mco.edu

This article has been cited by other articles:

				A.S. Samuel and R.K. Naz Isolation of human single chain variable fragment antibodies against specific sperm antigens for immunocontraceptive development Hum. Reprod., June 1, 2008; 23(6): 1324 - 1337. [Abstract] [Full Text] [PDF]

				B. G. Khobarekar, V. J. Vernekar, E. Prabagaran, V. P. Raghavan, and A. H. Bandivdekar Studies on the Expression of 80-kDa Human Sperm Antigen in Rat Testis and Epididymis J. Histochem. Cytochem., July 1, 2007; 55(7): 753 - 762. [Abstract] [Full Text] [PDF]

				J. Shi, Z. Yang, M. Wang, G. Cheng, D. Li, Y. Wang, Y. Zhou, X. Liu, and C. Xu Screening of an Antigen Target for Immunocontraceptives from Cross-Reactive Antigens between Human Sperm and Ureaplasma urealyticum Infect. Immun., April 1, 2007; 75(4): 2004 - 2011. [Abstract] [Full Text] [PDF]

				D. W Cooper and E. Larsen Immunocontraception of mammalian wildlife: ecological and immunogenetic issues. Reproduction, December 1, 2006; 132(6): 821 - 828. [Abstract] [Full Text] [PDF]

				J.-J. Chang, J.-P. Peng, Y. Yang, J.-L. Wang, and L. Xu Study on the antifertility effects of the plasmid DNA vaccine expressing partial brLDH-C4' Reproduction, January 1, 2006; 131(1): 183 - 192. [Abstract] [Full Text] [PDF]

				C. Bohring, E. Krause, B. Habermann, and W. Krause Isolation and identification of sperm membrane antigens recognized by antisperm antibodies, and their possible role in immunological infertility disease Mol. Hum. Reprod., February 1, 2001; 7(2): 113 - 118. [Abstract] [Full Text] [PDF]

				R. K. Naz, X. Zhu, and A. L. Kadam Identification of Human Sperm Peptide Sequence Involved in Egg Bindingfor Immunocontraception Biol Reprod, February 1, 2000; 62(2): 318 - 324. [Abstract] [Full Text]